Sign in
CompletedNo phase

Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.

Key facts

Who runs it
Benha University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
20 people enrolled
Started
1 Jan 2023
Ended
9 Jun 2026
Type of study
InterventionalOne group gets an existing treatment, for comparison.
Treatments tested
  • Baricitinib 4 MG Oral Tablet
Record updated
12 June 2026

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adults diagnosed clinically with Alopecia Areata
  • Severity of alopecia tool (SALT) score greater than 50
  • Only patients with disease duration exceeding six months but less than eight years will be included

Who cannot take part

  • Patients were excluded if they were pregnant or lactating, and had chronic hepatic or renal disease
  • Cases diagnosed with malignancy, scalp infections, or other types of alopecia will also excluded from the current study
  • Recent use of systemic treatment within the last 3 months or topical treatment within the last 4 weeks also will be excluded

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.

The group in the trial

  • Alopecia Areata adults with severity of alopecia tool more than 50 percent.Existing treatment, for comparison

    Adults aged between 18 to 50 years and having a severity of alopecia tool (SALT) score more than 50 pecent.

    Treatment: Baricitinib 4 MG Oral Tablet

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Serum Level of Interleukin-15 and Interferon Gamma in Alopecia Areata Patients Before and After Baricitinib Treatment
Record updated
12 June 2026